

Longevity for Investors: Big Returns + Longer Life
6 snips Jul 5, 2024
Join Dr. Greg Bailey, a medical doctor turned biotech entrepreneur, as he shares his journey from emergency medicine to building successful companies like Juvenessence. He discusses the booming market for longevity drugs, emphasizing the need for strong management and strategic investing. Greg offers insights on evaluating biotech teams, the importance of fitness and foundational health habits, and even the role of diet in longevity. Plus, he shares personal success stories, practical advice for new investors, and the potential impact of longevity on society.
AI Snips
Chapters
Books
Transcript
Episode notes
From ER Doctor To Biotech Founder
- Dr. Greg Bailey described his shift from emergency medicine to entrepreneurship and leading companies that created major drugs.
- He helped build firms that reached $28 billion market cap and later co-founded Juvenescence focused on aging.
Huge Upside In Early Biotech Bets
- Early-stage biotech can multiply small investments into life-changing returns if you back the right companies.
- Longevity may offer even larger returns than prior oncology or migraine successes, so early involvement matters.
Compress Morbidity For Social And Economic Gain
- Extending healthy years narrows the costly period of dependency at life's end and preserves societal productivity.
- A ten-year compression of morbidity returns personal and economic value by keeping people functional longer.